Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants.

MLA

Kang, Dongwei, et al. “Structure-Based Optimization of Thiophene[3,2-d]Pyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants.” Journal of Medicinal Chemistry, vol. 60, no. 10, May 2017, pp. 4424–43. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.7b00332.

APA

Kang, D., Zengjun Fang, Boshi Huang, Xueyi Lu, Heng Zhang, Haoran Xu, Zhipeng Huo, Zhongxia Zhou, Zhao Yu, Qing Meng, Gaochan Wu, Xiao Ding, Ye Tian, Daelemans, D., De Clercq, E., Pannecouque, C., Peng Zhan, & Xinyong Liu. (2017). Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants. Journal of Medicinal Chemistry, 60(10), 4424–4443. https://doi.org/10.1021/acs.jmedchem.7b00332

Chicago

Kang, Dongwei, Zengjun Fang, Boshi Huang, Xueyi Lu, Heng Zhang, Haoran Xu, Zhipeng Huo, et al. 2017. “Structure-Based Optimization of Thiophene[3,2-d]Pyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants.” Journal of Medicinal Chemistry 60 (10): 4424–43. doi:10.1021/acs.jmedchem.7b00332.